Macleod ivor 4

What Happened

• Ivor Macleod, Chief Financial Officer of SCYNEXIS, received a grant of 129,833 restricted stock units (RSUs) reported on Form 4 for the transaction date 2026-01-29. The award has an acquisition price of $0.00 (no cash paid) and thus a reported total value of $0 at grant.

Key Details

• Transaction date: 2026-01-29; Form 4 filed: 2026-02-02 (timely under the two-business-day filing rule).
• Grant type/code: A (award/grant); reported price per share: $0.00.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: RSUs vest one-third per year over three years as measured from February 28, 2026 (per filing footnote F1).
• No 10b5-1 plan, tax-withholding sale, or cashless exercise noted in the filing.

Context

• RSUs are a deferred equity award: they convert into shares only as they vest (subject to forfeiture until vesting) and do not represent an immediate sale or purchase. Grants are common for employee compensation and retention and do not by themselves indicate buying or selling sentiment.